- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 43.928 ↑ 0.45%
[as on 20 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
Mirae Asset Healthcare Fund Direct Growth | 0.03% | 0.45% | 0.63% | -0.75% | -0.35% | 1.66% | 23.26% | 19.5% | 22.75% | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
99.89% |
0.01% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.10% |
Equity
Name | Sector | Weight % |
---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 11.57% |
Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 7.76% |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 6.97% |
Apollo Hospitals Enterprise Ltd. | Healthcare Services | 6.23% |
Cipla Ltd. | Pharmaceuticals & Biotechnology | 6.03% |
Lupin Ltd. | Pharmaceuticals & Biotechnology | 5.05% |
Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 4.33% |
Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.19% |
Fortis Healthcare Ltd. | Healthcare Services | 4.19% |
Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.74% |
IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.49% |
Aster DM Healthcare Ltd. | Healthcare Services | 3.40% |
Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 3.30% |
Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 3.01% |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.81% |
Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.80% |
JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.78% |
Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.74% |
Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | 2.45% |
Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 2.29% |
Wockhardt Ltd. | Pharmaceuticals & Biotechnology | 1.87% |
Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.70% |
Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.62% |
Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 1.45% |
Biocon Ltd. | Pharmaceuticals & Biotechnology | 0.92% |
Deepak Nitrite Ltd. | Chemicals & Petrochemicals | 0.83% |
Sagility Ltd. | IT - Services | 0.81% |
Neogen Chemicals Ltd. | Chemicals & Petrochemicals | 0.56% |
Syngene International Ltd. | Healthcare Services | 0.51% |
Laxmi Dental Ltd. | Healthcare Equipment & Supplies | 0.48% |
Debt
Name | Rating | Weight % |
---|
Mirae Asset Liquid Fund-Direct Plan-Growth | | 0.01% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
Mirae Asset Healthcare Fund Direct Growth - 30 days NAV history
Date | NAV |
---|
20 October, 2025 | 43.928 |
17 October, 2025 | 43.730 |
16 October, 2025 | 43.641 |
15 October, 2025 | 43.445 |
14 October, 2025 | 43.331 |
13 October, 2025 | 43.651 |
10 October, 2025 | 43.600 |
9 October, 2025 | 43.192 |
8 October, 2025 | 42.882 |
7 October, 2025 | 43.037 |
6 October, 2025 | 42.948 |
3 October, 2025 | 42.582 |
1 October, 2025 | 42.529 |
30 September, 2025 | 42.189 |
29 September, 2025 | 42.207 |
26 September, 2025 | 42.130 |
25 September, 2025 | 42.972 |
24 September, 2025 | 43.222 |
23 September, 2025 | 43.508 |
22 September, 2025 | 43.659 |
19 September, 2025 | 44.260 |
18 September, 2025 | 44.010 |
17 September, 2025 | 43.660 |
16 September, 2025 | 43.771 |
15 September, 2025 | 43.670 |
12 September, 2025 | 43.877 |
11 September, 2025 | 43.789 |
10 September, 2025 | 43.613 |
9 September, 2025 | 43.447 |
8 September, 2025 | 43.104 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 43.928 as on 20 October, 2025.
What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 0.03% as on 20 October, 2025.
What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 1.66% as on 20 October, 2025.
What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 23.26% as on 20 October, 2025.
What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 19.5% as on 20 October, 2025.